| Application no. and date | 14761062.0 (espacenet) (Federated) (European Patent Register), 20140304 | | Patent/reg. no. and date | DK/EP 2964258, 20200902 | | Publication date | 20160113 | | Priority no. and date | US 201361774732 P, 20130308 | | EP pub. no. and date |
EP 2964258 20160113 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | V49629DK00 | | Inventor | BEIDLER, Catherine Brautigam, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288, US,
BRIGHT, Stuart Willis, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288, US,
GIRARD, Daniel Scott, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288, US,
KIKLY, Kristine Kay, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis
Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) | | Title | Antistoffer, der binder IL-23 | | Int. application no. | US2014020064 | | Int. publication no. | WO2014137962 | | Related patent (certificate) | CA 2023 00029 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
